These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 8107986)
1. Quantification of functional deficit in Alzheimer's disease using a computer-assisted mapping program for 99mTc-HMPAO SPECT. Karbe H; Kertesz A; Davis J; Kemp BJ; Prato FS; Nicholson RL Neuroradiology; 1994; 36(1):1-6. PubMed ID: 8107986 [TBL] [Abstract][Full Text] [Related]
2. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. van Dyck CH; Lin CH; Smith EO; Wisniewski G; Cellar J; Robinson R; Narayan M; Bennett A; Delaney RC; Bronen RA; Hoffer PB J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168 [TBL] [Abstract][Full Text] [Related]
3. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern. Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614 [TBL] [Abstract][Full Text] [Related]
4. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830 [TBL] [Abstract][Full Text] [Related]
5. Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection. Claus JJ; van Harskamp F; Breteler MM; Krenning EP; van der Cammen TJ; Hofman A; Hasan D Eur J Nucl Med; 1994 Oct; 21(10):1044-51. PubMed ID: 7828613 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,l-HMPAO SPECT study. Waldemar G; Bruhn P; Kristensen M; Johnsen A; Paulson OB; Lassen NA J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):285-95. PubMed ID: 8158175 [TBL] [Abstract][Full Text] [Related]
8. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease. Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017 [TBL] [Abstract][Full Text] [Related]
9. A study of regional cerebral blood flow using 99mTc-HMPAO-SPECT in elderly women with senile dementia of Alzheimer's type. Elmståhl S; Siennicki-Lantz A; Lilja B; Bjunö L Dementia; 1994; 5(6):302-9. PubMed ID: 7866483 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional display of surface cortical perfusion by SPECT: application in assessing Alzheimer's disease. Hashikawa K; Matsumoto M; Moriwaki H; Oku N; Okazaki Y; Seike Y; Uehara T; Tanabe H; Ohie Y; Kamada T J Nucl Med; 1995 Apr; 36(4):690-6. PubMed ID: 7699466 [TBL] [Abstract][Full Text] [Related]
11. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type. Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144 [TBL] [Abstract][Full Text] [Related]
12. Regional HmPAO SPECT and CT measurements in the diagnosis of Alzheimer's disease. Mattman A; Feldman H; Forster B; Li D; Szasz I; Beattie BL; Schulzer M Can J Neurol Sci; 1997 Feb; 24(1):22-8. PubMed ID: 9043743 [TBL] [Abstract][Full Text] [Related]
13. Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls. Wyper D; Teasdale E; Patterson J; Montaldi D; Brown D; Hunter R; Graham D; McCulloch J Br J Radiol; 1993 Jan; 66(781):23-7. PubMed ID: 8428246 [TBL] [Abstract][Full Text] [Related]
14. The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. Hunter R; McLuskie R; Wyper D; Patterson J; Christie JE; Brooks DN; McCulloch J; Fink G; Goodwin GM Psychol Med; 1989 Nov; 19(4):847-55. PubMed ID: 2594881 [TBL] [Abstract][Full Text] [Related]
15. SPECT for differential diagnosis of dementia and correlation of rCBF with cognitive impairment. Osimani A; Ichise M; Chung DG; Pogue JM; Freedman M Can J Neurol Sci; 1994 May; 21(2):104-11. PubMed ID: 8087734 [TBL] [Abstract][Full Text] [Related]
16. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. Perani D; Di Piero V; Vallar G; Cappa S; Messa C; Bottini G; Berti A; Passafiume D; Scarlato G; Gerundini P J Nucl Med; 1988 Sep; 29(9):1507-14. PubMed ID: 3261784 [TBL] [Abstract][Full Text] [Related]
17. Measurement of cerebral perfusion volume and 99mTc-HMPAO uptake using SPECT in controls and patients with Alzheimer's disease. Fleming JS; Kemp PM; Bolt L; Goatman KA Nucl Med Commun; 2002 Nov; 23(11):1057-64. PubMed ID: 12411833 [TBL] [Abstract][Full Text] [Related]
18. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease. Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of SPECT with Tc 99m HMPAO in Alzheimer's disease: a population-based study. Claus JJ; van Harskamp F; Breteler MM; Krenning EP; de Koning I; van der Cammen TJ; Hofman A; Hasan D Neurology; 1994 Mar; 44(3 Pt 1):454-61. PubMed ID: 8145915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]